Eli Casdin

Filings by Eli Casdin span 7 companies, the busiest being Standard Biotools Inc., GeneDx Holdings Corp. and SomaLogic, Inc. Over a trading history stretching from 22 June 2021 to 18 June 2026, the count stands at 32 filings.

Purchases make up the whole of the open-market record (4 purchases, €73.3M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 13 share grants and 7 option exercises.

A typical purchase (the median) is worth €14.6M. Of 4 purchases, 4 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time.

The latest filing, published on 23 June 2026, reports a share grant in Standard Biotools Inc. The most recent open-market purchase was published on 19 May 2023, 1,248 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.